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Nebulizer output using patient simulation 
N. Schaefer, S.G Devadason 
School of Paediatrics arm ChiM Health, University of Western Australia, WA 6008 
AIMS: Certain nebulise~ s (nebs) rely on the patient's interaction to enhance chug output 
while other semit a continuous aerosol independent of patient resph ation. To determine file 
most suited esign for different patients, we assessed nebs of varying opetating plinciples 
in ¢itro, with and without patient resphatory simulation. METHODS: The Malvern 
Maste~ size~ X was used to calculate the free particle fi action (FPF) and volumetric mean 
diameter (VMI)) for Neath assisted, vented nebs, LC Plus (LCP) and LC Stm (LCS; Pari); 
vented, passive entrainment eb, Sidestream (SS; Medic Aide); and conventional jet neb, 
Micromist (MM; Hudson RCI) in triplicate. Data was obtained from each neb (n6)  with 
no patient respiratoo, simulation, and with adult (30L/rain flow), child (10L/rain) and 
infant simulation (5L/rain). RESULTS: The LCP and LCS showed a significantly 
increased FPF and lower VMI) when applying the child and adult resphatoo, flow 
(D=0.005), but the infant simulation had no significant effect (p>0.05). There was no 
significant eft?ct of patient simulation on the SS and MM. ~ne MM showed considei able 
variability in FPF (D=0.006) and VMI) (p~).005) compm ed to the LCP, LCS and SS. 
Neb FPF(%) [SD] 
OL/min 5L/rain lOL/min 30L/rain 
LCP 500117] 507 [12] 554 [16] 705 [16] 
LCS 671132] 670 [27] 712 [09] 767 [17] 
SS 675[25] 697 [16] 712 [14] 
MM 615143] 599 [51] 599 [51] 
Neb VMD(~'m) SD] 
OL/min 5L/rain lOL/min 30L/rain 
LCP 481016] 47 [011] 44  [013] 35 [006] 
LCS 361018] 36 [015] 34 [005] 32 [009] 
SS 381013] 37 [010] 37 [007] 
MM 40[077] 41 [036] 41 [033] 
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A review of 168 totally implantable venous access devices [TIVAD's] 
inserted over an 8 year period [1995-2002] in a Regional Adult CF 
Centre 
C. Etheringt on, E. Jones, D. Peckham, S.P. Conway 
Regional Adult Cystic Fibrosis Unit, Seacrof~ Hospital, Leeds, England. LSI4 6UH 
Introduct ion.  TIVAD's have an essential role ha the delivery of antibiotics in CF 
patients. It is important to inform the patient ful ly of the risks and benefits. 
Methods. A retrospective r view of case records was performed on all TIVAD's 
inserted between January 1995 mad December 2CO2. Details of TIVAD insertion, 
duration of fimction, complications and reasons for removal were collected. 
Results. A total of 168 TIVAD's were inserted in 128 patients. Mean number 
21/year. 2 patients had failed insertion due to pneumothor ax. 91 [71%] received one 
device, 28 [22%] received two, 6 [5%] received three and 3 [2%] received four. At 
the end of the study period 65 devices were still ha situ [39%], with duration of 
function of 0.3 7.7 years [median 3.1 years]. In 29 cases [17%] the patient died with 
the device in situ. 74 devices were removed [44%]. 13 [18%] were removed at the 
t ime of transplantation, 19 [26%] due to infection, 12 [16%] due to catheter 
occlusion and 4 [5%] due to vascular thrombosis. Mechanical thilure accounted for 
removal of 18 devices [24%]. In the remaining 8 [11%], reasons for removal were 
unknown. The median life span of those removed was 2.1 years [range 0 .045 .8  
years]. 56 complications cecurred in 168 devices, an overall complication rate of 
33%, which is lower than previously reported [1]. Incidence of infection was 11.2%, 
catheter occlusion 7%, catheter leakage 4.7%, vascular thrombosis 3.5%, 
detachment and migration of catheter 3.5%, fractured l ine 0.6%, paha/malposition 
1.8% and pneumothor ax 1.2%. 
Condusions.  TIVAD's appear to be safe and effective for long term venous access, 
but complications may occur in up to one third of devices. 
Reference: [1] Munck A et al. Eur Respir J 2CO4; 23:430 434. 
CONCLUSIONS: Active entrainment ebs delivered more spitable particles using 
child and adult respiratory flows than passive ntrainment and conventional nebs. There 
was no significant advantage to using active enti aiimaent nebs in infants compmed to 
the passive ntt ainment neb. 
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Endovascular stripping as a valuable tool to beat distal occlusions of 
Totally Implantable Vascular Devices in CF 
D. Sistek 1, M. Hofer 1, S.D. Qanadli 2, A. Sauty 1
~Department of Pneumology, CHUV, Lausanne, Switzerlarul, 2Department of 
Radiology, CHU~,," Lausanne, Switzerlarul 
I n rmduet ion :  Totally implantable vascular access devices (TIVAD) are widely 
used ha cystic fibrosis (CF). Most frequent long term complications are absence of 
blood reflux (partial occlusion) and total occlusions, fol lowing by infections, 
catheter uptures and vascular tbrombosis. TIVAD occlusion is prevented by 
heparin, but in case of partial or total occlusion, use of ur okinase is recommended. 
An  alternative approach is endovascular catheter stripping (ECS) of TIVAD and we 
present, here, our experience with this method ha CF patients. 
Mater ia l  and  methods:  We reviewed all the events that occurred to TIVAD 
implanted ha adult CF patients between 1995 and 2CO4 in our institution. We 
collected the number of complications and the procedures of TIAVD desccclusion 
(ECS mad ur okinase injection) 
Results: Out of the 24 CF adult patients from whom data were available, a TIVAD 
was implanted ha 13 (56%). Mean duration of TIVAD was 32 months (range 7 to 
101 months). Out of the 18 reported complications, 11 (61%) were due to a total or 
partial occlusion. Urokinase injection was performed 6 cases but failed in 2. In the 
situation where a partial and distal occlusion was found by the radiologist, ECS was 
performed within 48h as the first choice. ECS was wel l  supported and was 
successful ha 5/5 cases with no complications. 
Conclusion: Endovascular catheter stripping may be a effective alternative to 
ur okinase in case of partial and istal TIVAD occlusion in CF patients. 
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Ca/Mg ratio: an index predicfive of urolithiasis in cystic fibrosis 
S. Giour tzis, M. Fot oulaki, 1% Panagopoulou, V. Lafazanis, S. Nous ia~r  vanitakis 
Fourth Department of Pediatrics, Aristotle University, Thessaloniki, GR 
Patients with cystic fibrosis (CF) have an increased incidence of kidney stone 
formation (urolithiasis). The a im of this study was to determine the potential r isk 
factors for renal stone formation ha CF patients. Mellaods: We compared the results 
of metabolic evaluation of 5 CF patients having confirmed urolithiasis, of 26 CF 
patients without urolithiasis and 10 healthy volunteers. The risk factors for renal 
stone formation were determined: 24h  ur ine collection for uric acid, calcium, 
oxalates, Mg, Ca, and cystine were examined and the ratio Ca/Mg was calculated. 
Glomerular fi ltration rate (GFR), the ratio of uric acid per I(X) ml  GFR, and the ratio 
Ca/Cr ha a sample of ur ine were calculated. Blood levels of C¥, Ca, phosphorus (P), 
P1TI, potassium (K), uric acid bicarbonates (HCO2) mad hydrogen ion 
concentrations were obtained. Fresh ur ine samples were examined for the presence 
of crystals and erytbrocytes. Results:  Hypercalciuria was detected ha two patients. 
One of them had ur olithiasis and hematuria. Hyperuricosuria was detected only in 
one patient, who did not have urolithiasis. Hyperoxallouria and cystinuria was not 
detected. The Ca/Mg ratio was increased in 3/5 patients having urolithiasis, 4/26 
patients without ur olithiasis and in 5/10 healthy volunteers. Dur ing the 2 year study 
period, 4/5 healthy vohmteers, who had abnormal Ca/Mg ratio, developed 
urolithiasis and 1/5 had a family histot3, of urolithiasis. Conclusion: The Ca/Mg 
ratio proved to be a valuable predictive factor of stone formation in CF patients. 
